Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Asset Utilization Ratio (2016 - 2026)

Ocular Therapeutix has reported Asset Utilization Ratio over the past 13 years, most recently at 0.07 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 51.08% year-over-year to 0.07; the TTM value through Mar 2026 reached 0.07, down 51.08%, while the annual FY2025 figure was 0.08, 54.28% down from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 0.07 at Ocular Therapeutix, down from 0.09 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.43 in Q2 2023 and troughed at 0.07 in Q1 2026.
  • A 5-year average of 0.22 and a median of 0.15 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 186.87% in 2022 and later crashed 73.39% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.33 in 2022, then fell by 15.69% to 0.28 in 2023, then plummeted by 52.35% to 0.13 in 2024, then tumbled by 36.57% to 0.09 in 2025, then decreased by 20.75% to 0.07 in 2026.
  • Business Quant data shows Asset Utilization Ratio for OCUL at 0.07 in Q1 2026, 0.09 in Q4 2025, and 0.13 in Q3 2025.